CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 144 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $21,000 | -56.2% | 105,800 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $48,000 | -9.4% | 105,800 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $53,000 | -78.5% | 105,800 | 0.0% | 0.00% | -80.0% |
| Q1 2018 | $247,000 | -17.7% | 105,800 | 0.0% | 0.01% | -16.7% |
| Q4 2017 | $300,000 | -1.0% | 105,800 | 0.0% | 0.01% | +9.1% |
| Q3 2017 | $303,000 | +16.1% | 105,800 | 0.0% | 0.01% | +10.0% |
| Q2 2017 | $261,000 | -31.7% | 105,800 | 0.0% | 0.01% | -33.3% |
| Q1 2017 | $382,000 | +1.9% | 105,800 | 0.0% | 0.02% | -6.2% |
| Q4 2016 | $375,000 | -12.2% | 105,800 | 0.0% | 0.02% | 0.0% |
| Q3 2016 | $427,000 | -8.0% | 105,800 | 0.0% | 0.02% | -15.8% |
| Q2 2016 | $464,000 | +16.0% | 105,800 | 0.0% | 0.02% | +11.8% |
| Q1 2016 | $400,000 | -75.9% | 105,800 | 0.0% | 0.02% | -71.7% |
| Q4 2015 | $1,659,000 | -53.5% | 105,800 | -68.7% | 0.06% | -53.1% |
| Q3 2015 | $3,567,000 | -72.9% | 338,400 | -66.7% | 0.13% | -79.3% |
| Q3 2014 | $13,178,000 | – | 1,016,800 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |